Tests an inhaled nitric oxide system for newborn lung pressure
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A clinician must decide you would benefit from inhaled nitric oxide and choose this device for your newborn
- Your newborn must be admitted to the hospital’s Neonatology unit
- Your newborn must have pulmonary hypertension and need breathing support now or soon
- Your oxygenation index (OI) must be at least 8 before starting treatment
- A parent or legal representative must sign informed consent after understanding the benefits and risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This study tests whether breathing in a special gas called nitric oxide can help people with moderate to severe ARDS (a severe form of lung failure that makes it hard to breathe). The gas is used to improve oxygen levels and may help patients on a ventilator recover.
This trial tests a portable device that delivers nitric oxide gas to help newborns with severe breathing problems and high blood pressure in the lungs. It aims to see if this treatment improves oxygen levels and supports recovery.
This trial tests a new, smart way to slowly reduce (wean) the inhaled nitric oxide gas that helps babies with a serious lung condition called PPHN. If your baby is already responding well to iNO and needs it for at least 24 hours, this study might help make the weaning process safer and more effective.
This trial tests whether giving a gas called inhaled nitric oxide helps newborns with a congenital diaphragmatic hernia breathe better and improve lung blood pressure. It's a type of treatment often used to help with lung problems in babies.
This trial studies whether stopping inhaled nitric oxide (a breathing medicine) can be safely used in newborns with congenital diaphragmatic hernia (CDH). It may help the team decide the best way to use this medicine during early newborn care.
Hear when a new Pulmonary Hypertension of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.